Dr. Jeff Donovan, 🇨🇦 Dermatologist (Hair Loss)(@DonovanMedical) 's Twitter Profile Photo

Not every patient with alopecia areata is a good candidate for a JAK inhibitor. Some reasons are reasons never to prescribe (absolute contraindication. Other reasons are reviewed on a case by case basis (relative contraindication).

Not every patient with alopecia areata is a good candidate for a JAK inhibitor. Some reasons are reasons never to prescribe (absolute contraindication. Other reasons are reviewed on a case by case basis (relative contraindication). #alopeciaareata #jakinhibitors
account_circle
@ReumatologiaJ(@ReumatologiaJ) 's Twitter Profile Photo

🔥A NEW study found
are not inferior in effectiveness to bDMARDs for severe .
✅It is important to monitor patients for thromboembolic events before and during JAK treatment.
👉bit.ly/39thXok

🔥A NEW study found 
✅#JAKinhibitors are not inferior in effectiveness to bDMARDs for severe #RheumatoidArthritis. 
✅It is important to monitor patients for thromboembolic events before and during JAK treatment.
👉bit.ly/39thXok
account_circle
Sophia Aldwinckle(@SophiaAldw) 's Twitter Profile Photo

We are excited to share this special focus issue on JAK inhibitors in autoimmune and inflammatory diseases in Expert Review of Clinical Immunology
tandfonline.com/toc/ierm20/cur…

We are excited to share this special focus issue on JAK inhibitors in autoimmune and inflammatory diseases in Expert Review of Clinical Immunology #immunology #rheumatology #jakinhibitors
tandfonline.com/toc/ierm20/cur…
account_circle
JAK Inhibitors and Inflammatory Arthritis Study(@ViewsJanus) 's Twitter Profile Photo

Short survey (≈10 mins) on the use of janus kinase inhibitors ( ) to treat rheumatoid arthritis ( ) or psoriatic arthritis ( ). For adults with RA/PsA who have current/previous use of a JAK inhibitor OR are on a biologic: surveymonkey.co.uk/r/ZBNDX8D.

Short #patient survey (≈10 mins) on the use of janus kinase inhibitors (#JAKinhibitors) to treat rheumatoid arthritis (#RA) or psoriatic arthritis (#PsA). For #UK adults with RA/PsA who have current/previous use of a JAK inhibitor OR are on a biologic: surveymonkey.co.uk/r/ZBNDX8D.
account_circle
ClinRheumatol(@ClinRheumatol) 's Twitter Profile Photo

A NEW systematic review of in LV
📌Tofacitinib is associated with better outcomes than MTX in TAK
📌JAKinibs reduce adventitial fibrosis, intimal proliferation, inflammatory vascular infiltrate in pre-clinical models of LVV
👉rdcu.be/cA1zN

A NEW systematic review of #JAKinhibitors in LV #vasculitis 
📌Tofacitinib is associated with better outcomes than MTX in TAK
📌JAKinibs reduce adventitial fibrosis, intimal proliferation, inflammatory vascular infiltrate in pre-clinical models of LVV
👉rdcu.be/cA1zN
account_circle
Dr Bevin Bhoyrul(@DrBevinBhoyrul) 's Twitter Profile Photo

Great to see our 📝 in JAAD Journals shedding light on comparative efficacy of & in areata
More JAK inhibitors coming through. Interesting to see how they compare in inducing regrowth in areata
Doctor Ahmed

Great to see our 📝 in @JAADjournals shedding light on comparative efficacy of #JAKinhibitors #tofacitinib & #baricitinib in #alopecia areata
More JAK inhibitors coming through. Interesting to see how they compare in inducing #hair regrowth in #alopeciaareata
@DrAhmedKazmi
account_circle
Sareum Holdings plc(@Sareumplc) 's Twitter Profile Photo

Today we announce the start of the food effects part of our Phase 1a clinical trial for lead program SDC-1801.

Find out more here: tinyurl.com/37tkkfw9

Sareum $SAR.L

Today we announce the start of the food effects part of our Phase 1a clinical trial for lead program SDC-1801.

Find out more here: tinyurl.com/37tkkfw9

Sareum $SAR.L #TYK2
#Drugdevelopment #JAKinhibitors #Autoimmune
account_circle
MJR(@MJR_journal) 's Twitter Profile Photo

𝐌𝐔𝐒𝐓 𝐑𝐄𝐀𝐃: John Isaacs and colleagues give a brief yet comprehensive overview of and their implications in .
👉📎 bit.ly/2YSntb5

𝐌𝐔𝐒𝐓 𝐑𝐄𝐀𝐃: @ProfJohnIsaacs and colleagues give a brief yet comprehensive overview of #JAKinhibitors and their implications in #rheumatology.
👉📎 bit.ly/2YSntb5
account_circle
AADmember(@AADmember) 's Twitter Profile Photo

To reduce flares as patients transition to , authors of a Dermatitis Journal article propose a tapering schedule for patients on immunosuppressants or dupilumab. - bit.ly/3FAVKlO

To reduce #atopicdermatitis flares as patients transition to #JAKinhibitors, authors of a @DermatitisJrnl article propose a tapering schedule for patients on immunosuppressants or dupilumab. #DermWorldWeekly - bit.ly/3FAVKlO
account_circle